Health Care [ 4/12 ] | Biotechnology [ 24/74 ]
NASDAQ | Common Stock
Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.
It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.
The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder.
In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post traumatic stress disorder and other health conditions.
The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021.
The company was incorporated in 2017 and is based in Vancouver, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 31, 23 | -11.44 Increased by +68.43% | - |
| Jul 31, 23 | -2.43 Increased by +93.19% | - |
| Apr 30, 23 | -16.62 Increased by +71.05% | - |
| Jan 31, 23 | -23.82 Increased by +39.80% | - |
| Oct 31, 22 | -36.24 Increased by +24.90% | - |
| Jul 31, 22 | -35.76 Decreased by -4.47 M% | - |
| Apr 30, 22 | -57.42 Decreased by -11.48 M% | - |
| Jan 31, 22 | -39.56 Decreased by -7.91 M% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | N/A Decreased by N/A% | -4.07 M Decreased by -65.47% | - - |
| Sep 30, 23 | 0.00 Decreased by N/A% | -4.07 M Decreased by -55.10% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -575.19 K Increased by +73.73% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -2.08 M Increased by +40.01% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -2.46 M Decreased by -17.63% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -2.62 M Decreased by -3.74% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -2.19 M Decreased by -102.21% | Decreased by N/A% - |
| Mar 31, 22 | 0.00 Decreased by N/A% | -3.46 M Decreased by -1.73 K% | Decreased by N/A% - |